AHN Launches RANDY'S Trial on Scar Tissue in Peritoneal Cancers
Image
Pittsburgh – October 16, 2026 -- Allegheny Health Network (AHN) Cancer Center has launched RANDY'S Trial, a clinical study funded by a gala that raised $44,000 in 2025, to test whether existing medications can break down fibrosis that blocks surgery in patients with appendiceal and other peritoneal cancers.
The trial is formally titled Repurposed And Naturally-Derived Drugs for the Treatment of Fibrosis in Peritoneal Carcinomatosis. It is supported by The Randy & Stephanie Meyer Spread Goodness Fund and is named for the late Lt. Randy Meyer II, a City of Pittsburgh firefighter who battled a rare form of appendix cancer for more than a decade.